Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Opiant Pharmaceuticals- Inc. (OPNT)

15.92 0.52 (3.38%)

06-19 09:35

Open:

15.4

Pre. Close:

15.4

High:

16

Low:

15.4

Volume:

790

Market Cap:

43M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

15.773 - 15.861

15.861 - 15.942

Low:

15.097 - 15.212

15.212 - 15.318

Close:

15.234 - 15.4

15.4 - 15.552

Technical analysis  (as of: 2018-06-19 10:07:03 AM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 19.70     One year: 21.02

Support:

Support1: 15.04    Support2: 12.51

Resistance:

Resistance1: 16.87    Resistance2: 18.00

Pivot:

15.75

Moving Averages:

MA(5): 15.50     MA(20): 15.99

MA(100): 19.49     MA(250): 23.27

MACD:

MACD(12,26): -0.68     Signal(12,26,9): -0.77

%K %D:

%K(14,3): 21.68     %D(3): 16.67

RSI:

RSI(14): 44.94

52-Week:

High: 51.9  Low: 5.06  Change(%): 179.3

Average Vol(K):

3-Month: 2286  10-Days 1513

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
OPNT has closed below upper band by 40.7%. Bollinger Bands are 56.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to OPNT's normal range. The bands have been in this narrow range for 11 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-16T16:44:42-04:00
FDA OKs first non-opioid treatment for opioid withdrawal

2018-05-08T17:13:50-04:00
Opiant Pharmaceuticals reports Q1 results

2018-04-26T03:18:20-04:00
Opioid prescriptions dropped 12% in 2017

2018-04-19T11:25:01-04:00
U.S. opioid prescriptions down 12% last year, largest drop in 25 years

2018-04-17T15:35:03-04:00
DEA aiming to collar production of opioids

2018-04-17T12:03:04-04:00
Sen. Sanders introduces bill to fine opioid makers for marketing practices

2018-04-11T05:49:01-04:00
Will Opiant Pharma Solve The Biggest Crisis That The FDA Is Currently Facing?

2018-03-20T14:56:08-04:00
Technology - Top Gainers / Losers as of 2.55 pm (3/20/18)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biopharmaceuticals

Shares Out. (M)

2.70

Shares Float (M)

% Held by Insiders

% Held by Institutions

4.10

Shares Short (K)

67

Shares Short Prior Month (K)

53

Stock Financials

EPS

0.420

EPS Est. Current Year

0.500

EPS Est. Next Year

1.250

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

7.070

PEG Ratio

Profit Margin

-54.25

Operating Margin

12.62

Return on Assets (ttm)

-87.7

Return on Equity (ttm)

-197.0

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-3.177

Qtrly Earnings Growth

Operating Cash Flow (M)

-9.22

Levered Free Cash Flow (M)

atoplab.com

Valuation

P/E

37.90

P/E Growth Ratio

0.03

P/BV

2.25

P/S

3181643.25

P/CF

-4.66

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2014-12-31

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.